Overview

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

Status:
Completed

Trial end date:
2019-07-31

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to evaluate the safety and tolerability of long-term administration of Lacosamide at doses up to 400 mg/day in Japanese and Chinese adults with Epilepsy who have completed the Treatment and Transition Period of EP0008 [NCT01710657]

Phase:

Phase 3

Details

Lead Sponsor:

UCB Pharma SA

Collaborator:

UCB Japan Co. Ltd.

Treatments:

Lacosamide